Japan, Jan. 28 -- ELI LILLY & CO has got intellectual property rights for 'RECOMBINANTLY ENGINEERED, LIPASE/ESTERASE-DEFICIENT MAMMALIAN CELL LINES.' Other related details are as follows:

Application Number: JP,2024-152049

Category (FI): A61K39/395@J,A61K39/395@N,C12N5/10,C12N15/55,C12P21/02@C,C12N5/16,C12N15/09,100,A61K47/26,C12P21/08

Stage: Grant (IP right document published.)

Filing Date: Sept. 4, 2024

Publication Date: Nov. 21, 2024

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....